Clayton is focused on evaluating genome editing technology for therapeutic development at Life Edit Therapeutics. He has more than a decade of experience in cell and molecular biology.
Prior to Life Edit, Clayton spent two years developing AAV-based gene therapy strategies as a Scientist at StrideBio.
Clayton received a BS in Microbiology from the University of Georgia, a MS in Biology from Georgia College and State University, and a PhD in Microbiology from North Carolina State University. He completed his postdoctoral training in genetics at the University of North Carolina, Chapel Hill.